Literature DB >> 25252608

Individual patient monitoring in daily clinical practice: a critical evaluation of minimal important change.

Jos Hendrikx1, Jaap Fransen, Wietske Kievit, Piet L C M van Riel.   

Abstract

PURPOSE: In daily practice, physicians translate knowledge from clinical trials to practice, to improve health in individual patients. To help interpret meaningful change on disease outcome measures, the concept of minimal important change (MIC) was conceived. The objective of this study was to investigate whether MIC values are suited for individual patient monitoring.
METHODS: Three main elements of the MIC concept were evaluated: (1) MIC values for improvement and deterioration were determined, and the amount of misclassification present in quantifying minimal change was analyzed. (2) Discordance between change categories (improved, unchanged, deteriorated), defined by the MIC values, and patients' satisfaction with their health was inspected. (3) Discordance between change categories, defined by MIC values, and patients' willingness to alter therapy was inspected.
RESULTS: MIC value analysis was based on 469 patients with RA seen in daily practice. The chance of falsely classifying health change of an individual patient was high (false-positive range 19-30 % and false-negative range 43-72 %). Of patients classified as improved, 24 % were not satisfied with their health and 69 % were not willing to change therapy. Of patients classified as deteriorated, 54 % were satisfied with their health and 57 % were not willing to change therapy.
CONCLUSIONS: The misclassification in the quantification of change and high proportions of discordance between change categories defined by MIC cutoff values and patients' satisfaction and willingness to alter therapy indicate that MIC values as such are not suited for individual patient monitoring.

Entities:  

Mesh:

Year:  2014        PMID: 25252608     DOI: 10.1007/s11136-014-0809-2

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  75 in total

1.  Patient outcomes in rheumatology. A review of measures.

Authors: 
Journal:  Arthritis Rheum       Date:  2003-10-15

Review 2.  Understanding the minimum clinically important difference: a review of concepts and methods.

Authors:  Anne G Copay; Brian R Subach; Steven D Glassman; David W Polly; Thomas C Schuler
Journal:  Spine J       Date:  2007-04-02       Impact factor: 4.166

Review 3.  Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice.

Authors:  Jaclyn Anderson; Liron Caplan; Jinoos Yazdany; Mark L Robbins; Tuhina Neogi; Kaleb Michaud; Kenneth G Saag; James R O'Dell; Salahuddin Kazi
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-05       Impact factor: 4.794

4.  Sufficiently important difference: expanding the framework of clinical significance.

Authors:  Bruce Barrett; David Brown; Marlon Mundt; Roger Brown
Journal:  Med Decis Making       Date:  2005 May-Jun       Impact factor: 2.583

5.  It's good to feel better but it's better to feel good and even better to feel good as soon as possible for as long as possible. Response criteria and the importance of change at OMERACT 10.

Authors:  Vibeke Strand; Maarten Boers; Leanne Idzerda; John R Kirwan; Tore K Kvien; Peter S Tugwell; Maxime Dougados
Journal:  J Rheumatol       Date:  2011-08       Impact factor: 4.666

6.  Baseline dependency of minimal clinically important improvement.

Authors:  Ying-Chih Wang; Dennis L Hart; Paul W Stratford; Jerome E Mioduski
Journal:  Phys Ther       Date:  2011-03-03

7.  What outcomes from pharmacologic treatments are important to people with rheumatoid arthritis? Creating the basis of a patient core set.

Authors:  T Sanderson; M Morris; M Calnan; P Richards; S Hewlett
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-05       Impact factor: 4.794

8.  Patient decision-making related to antirheumatic drugs in rheumatoid arthritis: the importance of patient trust of physician.

Authors:  Richard W Martin; Andrew J Head; Jonathan René; Timothy J Swartz; Justus J Fiechtner; Barbara A McIntosh; Margaret Holmes-Rovner
Journal:  J Rheumatol       Date:  2008-02-15       Impact factor: 4.666

9.  "Feeling better" or "feeling well" in usual care of hip and knee osteoarthritis pain: determination of cutoff points for patient acceptable symptom state (PASS) and minimal clinically important improvement (MCII) at rest and on movement in a national multicenter cohort study of 2414 patients with painful osteoarthritis.

Authors:  Serge Perrot; Philippe Bertin
Journal:  Pain       Date:  2012-10-30       Impact factor: 6.961

10.  Three ways to quantify uncertainty in individually applied "minimally important change" values.

Authors:  Henrica C W de Vet; Berend Terluin; Dirk L Knol; Leo D Roorda; Lidwine B Mokkink; Raymond W J G Ostelo; Erik J M Hendriks; Lex M Bouter; Caroline B Terwee
Journal:  J Clin Epidemiol       Date:  2009-06-21       Impact factor: 6.437

View more
  3 in total

1.  The challenge of measuring intra-individual change in fatigue during cancer treatment.

Authors:  Carol M Moinpour; Gary W Donaldson; Kimberly M Davis; Arnold L Potosky; Roxanne E Jensen; Julie R Gralow; Anthony L Back; Jimmy J Hwang; Jihye Yoon; Debra L Bernard; Deena R Loeffler; Nan E Rothrock; Ron D Hays; Bryce B Reeve; Ashley Wilder Smith; Elizabeth A Hahn; David Cella
Journal:  Qual Life Res       Date:  2016-07-28       Impact factor: 4.147

2.  Monitoring rheumatoid arthritis using an algorithm based on patient-reported outcome measures: a first step towards personalised healthcare.

Authors:  Jos Hendrikx; Jaap Fransen; Piet L C M van Riel
Journal:  RMD Open       Date:  2015-11-19

Review 3.  Minimal important change (MIC): a conceptual clarification and systematic review of MIC estimates of PROMIS measures.

Authors:  Caroline B Terwee; John Devin Peipert; Robert Chapman; Jin-Shei Lai; Berend Terluin; David Cella; Philip Griffith; Lidwine B Mokkink
Journal:  Qual Life Res       Date:  2021-07-10       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.